For years to come, the US healthcare market will remain the most attractive to providers of medical services. Considerable absolute sales figures and high expected growth are supported by a robust economy and political stability. Access to healthcare in general and medicines in particular is unmatched globally. Patients, prescribers and payers are accustomed to the newest and, by definition, most expensive therapeutics and diagnostics. However, we note that the forecast conceals regional variations in growth prospects.
Factors such as demographics, rural/urban splits, economic prosperity and affiliation to health insurance schemes vary between regions, and help determine where opportunities, and risks, lie in the US's regional healthcare market.